GUIDUCCI, SERENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.160
EU - Europa 12.094
AS - Asia 3.010
OC - Oceania 236
AF - Africa 112
SA - Sud America 27
Continente sconosciuto - Info sul continente non disponibili 12
Totale 33.651
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.118
RU - Federazione Russa 4.060
PL - Polonia 2.685
IT - Italia 2.204
IE - Irlanda 1.194
SE - Svezia 888
SG - Singapore 880
HK - Hong Kong 728
CN - Cina 625
FI - Finlandia 312
IN - India 282
AU - Australia 232
DE - Germania 190
GB - Regno Unito 154
JO - Giordania 139
UA - Ucraina 138
TR - Turchia 102
ID - Indonesia 101
CI - Costa d'Avorio 84
VN - Vietnam 69
CH - Svizzera 64
NL - Olanda 51
ES - Italia 50
CA - Canada 41
KR - Corea 41
FR - Francia 37
BR - Brasile 18
BE - Belgio 12
EU - Europa 12
JP - Giappone 10
AT - Austria 8
SC - Seychelles 8
EG - Egitto 7
LT - Lituania 7
RO - Romania 6
TW - Taiwan 6
CM - Camerun 5
CZ - Repubblica Ceca 5
LV - Lettonia 5
IR - Iran 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
HU - Ungheria 3
IL - Israele 3
MY - Malesia 3
NO - Norvegia 3
PH - Filippine 3
VE - Venezuela 3
ZA - Sudafrica 3
AL - Albania 2
AR - Argentina 2
BA - Bosnia-Erzegovina 2
GE - Georgia 2
MU - Mauritius 2
PE - Perù 2
PK - Pakistan 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SL - Sierra Leone 2
TH - Thailandia 2
YE - Yemen 2
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
HR - Croazia 1
IM - Isola di Man 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MK - Macedonia 1
MX - Messico 1
UZ - Uzbekistan 1
Totale 33.651
Salva come PNG Salva come JPEG
Città #
Santa Clara 4.465
Warsaw 2.682
Fairfield 2.212
Chandler 1.186
Dublin 1.186
Ashburn 1.067
Woodbridge 1.025
Seattle 907
Cambridge 869
Houston 778
Singapore 716
Wilmington 686
Hong Kong 433
Florence 357
Princeton 349
Lawrence 347
Altamura 340
Ann Arbor 296
Jacksonville 262
Melbourne 224
Beijing 205
Mumbai 204
Boston 200
Boardman 166
Moscow 156
Medford 154
Rome 140
Milan 126
San Diego 126
Shanghai 114
Buffalo 110
Jakarta 100
Abidjan 84
Izmir 78
Falls Church 75
Norwalk 65
Pune 61
Helsinki 57
Dong Ket 54
New York 54
Yubileyny 49
Bern 44
Hillsboro 44
Kent 44
Los Angeles 38
West Jordan 38
London 35
Naples 35
Turin 34
Seoul 31
Andover 30
Barcelona 30
Redwood City 20
Toronto 20
Bologna 19
Phoenix 18
Cagliari 17
Catania 16
Guangzhou 15
Padova 14
Washington 14
Bari 13
Redmond 12
Shenzhen 12
Brussels 11
Dearborn 11
Venice 11
Castelliri 10
Düsseldorf 10
Lauterbourg 10
Reggio Emilia 10
Genoa 9
Munich 9
Salerno 9
Chicago 8
Falkenstein 8
Lucca 8
Nanjing 8
Scandicci 8
Auburn Hills 7
Brescia 7
Laurel 7
Livorno 7
Messina 7
Moie 7
Pisa 7
Stockholm 7
Vicenza 7
Zurich 7
Ankara 6
Bremen 6
Cairo 6
Campi Bisenzio 6
Ferrara 6
Hefei 6
Lappeenranta 6
Prato 6
Sesto Fiorentino 6
Tappahannock 6
Verona 6
Totale 23.634
Salva come PNG Salva come JPEG
Nome #
ENDOMETRIOSI E MALATTIE REUMATICHE: LA PUNTA DELL’ICEBERG DEI NUMEROSI DISTURBI MESTRUALI IN CORSO DI MALATTIA REUMATICA 926
Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide 296
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 258
Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient. 256
[The treatment of diffuse cutaneous systemic sclerosis with autologous hemopoietic stem cells transplantation (HSCT): our experience on 2 cases]. 253
[Peripheral nervous system in limited systemic sclerosis]. 247
Interstitial lung disease in systemic sclerosis: Where do we stand? 244
Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis 241
The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn). 238
Anti-Fas IgM monoclonal antibody (anti-Fas mAb) effect on haemophilic arthropathy (HA) synoviocytes 231
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis. 227
The crowded crossroad to angiogenesis in systemic sclerosis: where is the key to the problem? 227
[Vasculogenesis and angiogenesis: vascular damage in systemic sclerosis]. 226
Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis 219
A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients. 219
Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide 216
High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis. 212
Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis 202
Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population 200
Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. 194
The "myth" of loss of angiogenesis in systemic sclerosis: A pivotal early pathogenetic process or just a late unavoidable event? 192
GLI INTERVENTI INFERMIERISTICI RIVOLTI AI PAZIENTI AFFETTI DA MALATTIE REUMATICHE SOTTOPOSTI A TERAPIA CON FARMACI BIOLOGICI: REVISIONE SISTEMATICA DELLA LETTERATURA 183
Assessment, definition, and classification of lower limb ulcers in systemic sclerosis: A challenge for the rheumatologist 160
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 160
Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis 160
Vascular leaking, a pivotal and early pathogenetic event in systemic sclerosis: should the door be closed? 155
Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis 155
Systemic sclerosis-like histopathological features in the myocardium of uPAR-deficient mice 149
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 147
The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction 147
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study 144
Sintomatologia gastrointestinale e qualità di vita dei pazienti affetti da Sclerosi Sistemica 142
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis 142
Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implications 141
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study 141
Severe fibrotic changes and altered expression of angiogenic factors in maternal scleroderma: placental findings. 141
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 140
The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs 136
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 134
Neuropeptides activate TRPV1 in rheumatoid arthritis fibroblast-like synoviocytes and foster IL-6 and IL-8 production. 134
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis 134
Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium 134
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 134
Angiostatic and Angiogenic Chemokines in Systemic Sclerosis: An Overview 133
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 132
A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis 131
Calcinosis in systemic sclerosis: subsets, distribution and complications 131
Activin, a grape seed derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis. 130
The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis. 130
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? 130
Differential expression of junctional adhesion molecules in different stages of systemic sclerosis 129
Effect of Dysmetabolisms and Comorbidities on the Efficacy and Safety of Biological Therapy in Chronic Inflammatory Joint Diseases 128
Treatment options in systemic sclerosis 128
Lack of activation of renal functional reserve predicts the risk of significant renal involvement in systemic sclerosis. 126
Functional disability and its predictors in systemic sclerosis: A study from the DeSScipher project within the EUSTAR group 126
Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro 126
Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis 125
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 124
Stiff skin syndrome: evidence for an inflammation-independent fibrosis? 124
The safety of iloprost in systemic sclerosis in a real-life experience 124
Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis. 122
Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis. 121
Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis. 121
Angiotensin-converting enzyme in systemic sclerosis: from endothelial injury to a genetic polymorphism. 120
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 120
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis. 120
Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis. 119
Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications 119
Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis 119
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 118
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). 117
Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis 117
Digital ulcers predict a worse disease course in patients with systemic sclerosis 117
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. 117
Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes. 116
Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis 116
Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. 115
Induced sputum in systemic sclerosis interstitial lung disease: Comparison to healthy controls and bronchoalveolar lavage 115
Update of EULAR recommendations for the treatment of systemic sclerosis. 115
Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement 113
European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research. 113
Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis. 112
2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative 112
Disease Activity Improvement in Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Inhibitors Correlates with Increased Soluble Fas Levels. 111
Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis 111
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 111
The renal resistive index, a new biomarker for the follow up of vascular modifications in Systemic Sclerosis 111
Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes. 110
Systemic sclerosis and infections. 109
Immunosuppression for interstitial lung disease in systemic sclerosis. 109
THE CROSSTALK OF THE SKIN-ORAL-GUT MICROBIOME AXIS IN LIMITED AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS 109
Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review 108
Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma? 107
Etrurians vs Greeks: May ACE I/D polymorphism still be considered as a marker of susceptibility to SSc? 107
Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage 107
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 107
Autologous stem cell transplantation improves microcirculation in systemic sclerosis 105
Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre 105
Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor. 104
Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. 104
Totale 15.443
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.292
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.292
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.365 0 0 0 0 0 0 528 573 500 318 361 85
2020/20213.089 268 213 187 504 134 269 168 214 314 438 207 173
2021/20222.034 48 182 164 86 92 128 61 155 139 74 269 636
2022/20235.199 558 982 177 373 389 920 672 253 511 97 175 92
2023/20243.008 85 273 447 158 200 383 150 513 87 298 254 160
2024/202511.993 635 1.721 1.015 2.497 4.217 1.866 42 0 0 0 0 0
Totale 34.084